A Critical Review of Properties of Modafinil and Analytical, Bioanalytical Methods for its Determination

References

• Anees, A. K.; Susanta, K. P.; Sudhir, K. S.; Arun, K. D. Stability indicating RP-HPLC method for determination of modafinil in bulk & its formulations. Int. J. Biol. Pharm. Res. 2011, 2(1), 39–44.
   Google Scholar
• Ballon, J. S.; Feifel, D. A systematic review of modafinil: Potential clinical uses and mechanisms of action. J. Clin. Psychiatry. 2006, 67, 554–566.
   PubMed Web of Science ®Google Scholar
• Becker, P. M.; Schwartz, J. R.; Feldman, N. T.; Hughes, R. J. Effect of modafinil on fatigue, mood, and health-related quality of life in patients with narcolepsy; Psychopharmacology 2004, 171, 133–139.
   PubMed Web of Science ®Google Scholar
• Becue, M. B. Confirmation of the structure of by-products in the synthesis of modafinil by liquid chromatography-mass spectrometry. J. Chromatogr. 1991, 557, 489–494.
   Web of Science ®Google Scholar
• Besset, A.; Tafti, M.; Villemin, E.; Billiard, M. The effects of modafinil (300 mg) on sleep, sleepiness and arousal in narcoleptic patients; Neurophysiol. Clin. 1993, 23, 47–60.
   PubMedGoogle Scholar
• Bharatiya, R.; Mishra, S.; Khuroo, A.; Satyanarayana, G. N. V. S.; Agarwal, V. K.; Sunil S. I.; Monif, T.; Pankaj, P. Liquid chromatography tandem mass spectrometry method for the estimation of modafinil in human plasma. World J. Pharm. Sci. 2014, 2(10), 1191–1197.
   Google Scholar
• Bhimanadhuni, C. C.; Garikapati, D. R.; Karamsetty, S. Development and validation of RP-HPLC method for determination of modafinil in bulk and dosage form. Int. Curr. Pharm. J. 2012, 1(4), 77–80.
   Google Scholar
• Boivin, D. B.; Montplaisir, J.; Petit, D.; Lambert, C.; Lubin, S. Effects of modafinil on symptomatology of human narcolepsy; Clin. Neuropharm. 1993, 16, 46–53.
   PubMed Web of Science ®Google Scholar
• Boyd, B.; Castaner, J. Armodafinil: Treatment of excessive sleepiness, α1-Adrenoceptor agonist; Drugs Fut. 2006, 3, 17–21.
   Web of Science ®Google Scholar
• Burnat, P.; Robles, F.; Do, B. High-performance liquid chromatographic determination of modafinil and its two metabolites in human plasma using solid-phase extraction. J. Chromatogr. B. 1998, 706, 295–304.
   PubMed Web of Science ®Google Scholar
• Carl Wright’, A. C. Stereochemistry and safety, efficacy and quality issues: Genesis of new regulations. Drug Inf. J. 1990, 24, 15.
   Google Scholar
• Cass, Q. B.; Galatti, T. F. A method for determination of the plasma levels of modafinil enantiomers, (±)-modafinic acid and modafinil sulphone by direct human plasma injection and bidimensional achiral-chiral chromatography. J. Pharm. Biomed. Anal. 2008, 46, 937–944.
   PubMed Web of Science ®Google Scholar
• Cass, Q. B.; Kohn, C. K.; Calafatti, S. A.; Aboul-Enein, H. Y. An enantioselective assay for (±)-modafinil. J. Pharm. Biomed. Anal. 2001, 26, 123–130.
   PubMed Web of Science ®Google Scholar
• Chen, Z.; Weber, S. G. Determination of binding constants by affinity capillary electrophoresis, electrospray ionization mass spectrometry and phase-distribution methods. Trends Anal. Chem. 2008, 27, 738–748.
   PubMed Web of Science ®Google Scholar
• Dackis, C. A.; Kampman, K. M.; Lynch, K. G.; Pettinati, H. M.; O’Brien, C. P. A double-blind, placebo-controlled trial of modafinil for cocaine dependence. Neuropsychopharmacology. 2005, 30, 205–211.
   PubMed Web of Science ®Google Scholar
• Dinges, D. F.; Arora, S.; Darwish, M.; Niebler, G. E. Pharmacodynamic effects on alertness of single doses of armodafinil in healthy subjects during a nocturnal perios of acute sleep loss. Curr. Med. Res. Opin. 2006, 22, 159–167.
   PubMed Web of Science ®Google Scholar
• Donovan, J. L.; Malcom R. J.; Markowitz, J. S.; DeVane, C. L. Chiral analysis of D- and L-modafinil in human serum: Application to human pharmacokinetic studies. Ther. Drug Monit. 2003, 25(2), 197–202.
   PubMed Web of Science ®Google Scholar
• Drouin, J. E.; Broquaire, M. Optimization of the mobile phase for the liquid chromatographic separation of modafinil optical isomers on a Chiral-AGP column. J. Chromatogr. 1992, 605, 19–31.
   Web of Science ®Google Scholar
• Dubey, S.; Ahi, S.; Reddy, I. M.; Beotra, A.; Jain, S. A novel study of screening and confirmation of modafinil, adrafinil and their metabolite modafinilic acid under EI-GC-MS and ESI-LC-MS-MS ionization. Indian J. Pharmacol. 41, 278–283, 2009.
   PubMedGoogle Scholar
• Duteil, J.; Rambert, F. A.; Pessonnier, J.; Hermant, J. F.; Gombert, R.; Assous, E. Central alpha l-adrenergic stimulation in relation to the behaviour stimulating effect of modafinil; Studies with experimental animals. Eur. J. Pharmacol. 1990, 180, 49–58.
   PubMed Web of Science ®Google Scholar
• Eipper, B. A.; Mains, R. E. Peptide α-amidation. Annu. Rev. Physiol. 1988, 50, 333–344.
   PubMed Web of Science ®Google Scholar
• Ferraro, L.; Antonelli, T.; O’Connor, W. T.; Tanganelli, S.; Rambert, F. A.; Fuxe, K. Modafinil: An antinarcoleptic drug with a different neurochemical profile to d-amphetamine and dopamine uptade blockers. Biol. Psychiatry. 1997, 42(12), 1181–1183.
   PubMed Web of Science ®Google Scholar
• Ferraro, L.; Antonelli, T.; Tanganelli, S.; O’Connor, W. T.; Perez de la Mora, M.; Mendez-Franco, J.; Rambert, F. A.; Fuxe, K. The vigilance promoting drug modafinil increases extracellular glutamate levels in the medial preoptic area and the posterior hypothalamus of the conscious rat: Prevention by local GABAA receptor blockade. Neuropsychopharmacology, 1999, 20, 346–356.
   PubMed Web of Science ®Google Scholar
• Ferraro, L.; Tanganelli, S.; O’Connor, W. T.; Antonelli, T.; Rambert, F.; Fuxe, K. The vigilance promoting drug modafinil increases dopamine release in the rat nucleus accumbens via the involvement of a local GABAergic mechanism. Eur. J. Pharmacol. 1996, 306, 33–39.
   PubMed Web of Science ®Google Scholar
• Fuxe, K.; Rambert, F. A.; Ferraro, L.; O’Connor, W.; Laurent, P. H.; Agnati, L. F.; Tanganelli, S. Preclinical studies with modafinil: Evidence for vigilance enhancement and neuroprotection. Drugs Today 1996, 32(Suppl. I):7–21.
   Web of Science ®Google Scholar
• Garnock-Jones, K. P.; Dhillon, S.; Scott, L. J. CNS Drugs. 2009, 23, 793–803.
   PubMed Web of Science ®Google Scholar
• Gaurang, P. P.; Hitendra, S. J. Stability indicating HPTLC method for estimation of modafinil in the bulk and tablet formulation. IOSR J. Pharm. Biol. Sci. 2013, 5, 22–28.
   Google Scholar
• Gorman, S. H. Determination of the D- and L-enantiomers of modafinil in human plasma utilizing liquid-liquid extraction and high performance liquid chromatography. J. Chromatogr. B. 1999, 730, 1–7.
   PubMed Web of Science ®Google Scholar
• Gorman, S. H. Determination of modafinil, modafinil acid and modafinil sulfone in human plasma utilizing liquid-liquid extraction and high-performance liquid chromatography. J. Chromatogr. B. 2002, 767, 269–276.
   PubMed Web of Science ®Google Scholar
• Jenner, P.; Zeng, B-Y.; Smith, L. A.; Pierce, R. K. B.; Tel, B.; Chancharme, L.; Moachon, G. Antiparkinsonian and neuroprotective effects of modafinil in the the mptp-treated common marmoset. Exp. Brain Res. 2000, 133, 178–188.
   PubMed Web of Science ®Google Scholar
• Khaldun, M. A. A.; Bahruddin, S.; Hassan, Y. A. Determination of the binding constants of modafinil enantiomers with sulfated β-cyclodextrin chiral selector by capillary electrophoresis using three different linear plotting methods. Electrophoresis. 2010, 31, 2957–2963.
   PubMed Web of Science ®Google Scholar
• Khaldun, M. A. A.; Bahruddin, S.; Rohana, A.; Muhammad, I. S. Enantioselective determination of modafinil in pharmaceutical formulations by capillary electrophoresis, and computational calculation of the inclusion complexes. Microchim. Acta. 2009, 166, 311–317.
   Web of Science ®Google Scholar
• Lagarde, D.; Batejat, D.; Van Beers, P.; Saraflan, D.; Pradella, S. Interest of modafinil, a new psychostimulant, during a sixty-hour deprivation experiment; Fundam. Clin. Pharmacol. 1995, 9, 271–279.
   PubMed Web of Science ®Google Scholar
• Markis, A. P.; Kelly, T. H.; Wilson, J. F. The effects of modafinil on food intake, verbal reports of drug effect, performance and cardiovascular activity in normal, healthy men and women. Drug Alcohol Depend. 2001, 63, S96.
   Google Scholar
• Martinez-Raga, J.; Knecht, C.; Cepeda, S. Modafinil: A useful medication for cocaine addiction? Review of the evidence from neuropharmacological, experimental and clinical studies. Drug Abuse Rev. 2008, 1, 213–221.
   PubMedGoogle Scholar
• McGregor, C.; Srisurapanont, M.; Mitchell, A.; Wickes, W.; White, J. M.; Symptoms and sleep patterns during inpatient treatment of methamphetamine withdrawal: A comparison of mirtazapine and modafinil with treatment as usual; J. Subst. Abuse Treat. 2008, 35, 334–342.
   PubMed Web of Science ®Google Scholar
• McKinney, A. R.; Suann, C. J.; Stenhouse, A. M. The detection of modafinil and its major metabolite in equine urine by liquid chromatography/mass spectrometry. Rapid Commun. Mass Spectrom. 2005, 19, 1217–1220.
   PubMed Web of Science ®Google Scholar
• Menza, M. A.; Kaufman, K. R.; Castellanos, A. Modafinil augmentation of antidepressant treatment in depression. J. Clin. Psychiatry, 2000, 61(5), 378–381.
   PubMed Web of Science ®Google Scholar
• Mignot, E.; Nishino, S.; Guilleminault, C.; Dement, W. C. Modafinil binds to the dopamine uptake carrier site with low affinity. Sleep. 1994, 17, 436–437.
   PubMed Web of Science ®Google Scholar
• Moachon, G.; Matinier, D. Simultaneous determination of modafinil and its acid metabolite by high-performance liquid chromatography in human plasma. J. Chromatogr. B. 1994, 654, 91–96.
   PubMed Web of Science ®Google Scholar
• Mu, B.; Lei, G.; He, X.; Du, X. Synthesis of central stimulant modafinil. Zhongguo Yaowu Huaxue Zazhi. 1999, 9(2), 132–134.
   Google Scholar
• Nishino, S.; Mao, J.; Sampath kumaran, R.; Shelton, J. Increased dopaminergic transmission mediates the wake-promoting effects of CNS stimulants. Sleep Res. Online 1998, 1, 49–61.
   PubMedGoogle Scholar
• Nithiananda, C.; James, P. S.; Hsin, W.; George, J. A. Anti-narcoleptic agent modafinil and its sulfone: A novel facile synthesis and potential anti-epileptic activity. Neurochem. Res. 2004, 29(8), 1481–1486.
   PubMed Web of Science ®Google Scholar
• Philmore, R. Jr., Edward, H. T. Clinical pharmokinetic profile of modafinil; Clin. Pharmacokinet. 2003, 42, 123–137.
   PubMed Web of Science ®Google Scholar
• Piérard, C.; Lallement, G.; Pérès, M.. Lagarde D. Modafinil: A Molecule of Military Interest. 2001, 77–87.
   Google Scholar
• Prisinzano, T.; Podobinski, J.; Tidgewell, K.; Luo, M.; Swenson, D. Synthesis and determination of the absolute configuration of the enantiomers of modafinil. Tetrahedron: Asymmetry. 2004, 15, 1053–1058.
   Web of Science ®Google Scholar
• Rao, R. N.; Dhananjay, D. S.; Kumar, M. V. N. T. Development and validation of a reversed phase liquid chromatographic method for separation and determination of related-substances of modafinil in bulk drugs. Talanta. 2007, 73, 407–414.
   PubMed Web of Science ®Google Scholar
• Rao, R. N.; Dhananjay, D. S.; Ramesh, V.; Srinivas, R. LC-MS of novel narcoepileptics and related substance. J. Sep. Sci. 2009, 32, 1312–1322.
   PubMed Web of Science ®Google Scholar
• Rao, R. N.; Ramachandra, B.; Santhakumar, K. Evaluation of (R)-(-)-α–methoxy phenyl acetic acid as a chiral shift reagent for resolution and determination of R and S enantiomers of modafinil in bulk drugs and formulations by HNMR spectroscopy. Chirality. 2012, 24, 339–344.
   PubMed Web of Science ®Google Scholar
• Rao, R. N.; Shinde, D. D. Enantioselective separation and determination of adrafinil and modafinil on Chiralcel OJ-H column in rat serum and urine using solid-phase extraction followed by HPLC. Biomed. Chromatogr. 2009, 23, 811–816.
   PubMed Web of Science ®Google Scholar
• Robertson, P.; Hellriegel, E. T. Clinical pharmacokinetic profile of modafinil. Clin. Pharmacokinet. 2003, 42, 123–137.
   PubMed Web of Science ®Google Scholar
• Roth, T.; Czeisler, C. A.; Walsh, J. K.; Wesnes, K. A.; Williams, M.; Niebler, G. E.; Arora, S. Neuropsychopharmacology. 2005, 30(Suppl), S140.
   Google Scholar
• Rundlett, K. L.; Armstrong, D. W. Methods for the estimation of binding constants by capillary electrophoresis. Electrophoresis. 1997, 18, 2194–2202.
   PubMed Web of Science ®Google Scholar
• Schwertnera, H. A.; Kong, S. B. Determination of modafinil in plasma and urine by reversed phase high-performance liquid-chromatography. J. Pharm. Biomed. Anal. 2005, 37, 475–479.
   PubMed Web of Science ®Google Scholar
• Seshamamba, B. S. V.; Satyanarayana, P. V. V.; Sekaran, C. B. Simple spectrophotometric methods for quantification of modafinil using 1,2-naphthoquinone-4-sulphonate and 2,4-dinitrophenol as analytical reagents. Iran. Chem. Commun. 2014, 2, 255–268.
   Google Scholar
• Swetha, K.; Mohideen, S.; Satyanarayana, T.; Narasimha, R. Ch.; Suresh, K. P.; Shyamala, M. Determination and validation of modafinil in pharmaceutical formulation by RP-HPLC method. Int. J. Res. Pharm. Biomed. Sci. 2011, 2(4).
   Google Scholar
• Taylor, F. B.; Russo, J. Efficacy of modafinil compared to dextroamphetamine for the treatment of attention deficit hyperactivity disorder in adults. Child Adolesc. Psychopharmacol. 2000, 10(4), 311–320.
   PubMed Web of Science ®Google Scholar
• Teitelman, E. Off-label uses of modafinil. Am. J. Psychiatry, 2001, 158(8), 1341.
   PubMed Web of Science ®Google Scholar
• Thierry, G.; Pierre-Hervé, L.; Francis, A. R.; Armand, F.; Patrice, F. Effect of the wake-promoting agent modafinil on sleep-promoting neurons from the ventrolateral preoptic nucleus: An in vitro pharmacologic study. Sleep. 2004, 27, 1.
   Google Scholar
• Tseng, Y. L.; Uralets, Victor.; Lin, C-T.; Kuo, F-H. Detection of modafinil in human urine by gas chromatography-mass spectrometry. J. Pharm. Biomed. Anal. 2005, 39, 1042–1045.
   PubMed Web of Science ®Google Scholar
• Vilas, C.; Milind, U. A validated stability-indicating HPLC assay method for modafinil HCl in bulk drug. Int. J. Pharm . Chem. Sci. 2013, 2(1).
   Google Scholar
• Vivek, S. P.; Nelofer, B.; S. Shobha, R. S. Stability indicating RP-HPLC method for the estimation of armodafinil in tablet dosage form. Int. J. Pharm. Pharm. Sci. 2014, 6(8).
   Google Scholar
• Warot, D.; Corruble, B.; Payan, C.; Weil, J. S.; Peuch, A. J. Subjective effects of modafinil, a new central adrenergic stimulant in healthy volunteers: A comparison amphetamine, caffeine and placebo. Eur. Psychiatry. 1993, 8, 201–208.
   Google Scholar
• Wong, Y. N.; King, S. P.; Simcoe, D.; Gorman, S.; Laughton, W.; McCormick, G. C.; Grebow, P. Open-label, single-dose pharmacokinetic study of modafinil tablets: Influence of age and gender in normal subjects. J. Clin. Pharmacol. 1999, 39, 281–288.
   PubMed Web of Science ®Google Scholar
• Wong, Y. N.; Simcoe, D.; Hartman, L. N.; Laughton, W. B.; King, S. P.; McCormick, G. C.; Grebow, P. E. A double-blind, placebo-controlled, ascending-dose evaluation of the pharmacokinetics and tolerability of modafinil tablets in healthy male volunteers. J. Clin. Pharmacol. 39, 30–40, 1999.
   PubMed Web of Science ®Google Scholar
• Younus, M.; Fasiuddin, A. M.; Richards, M. P.; Kumar, D. B. Determination of venlafaxine and modafinil in individual tablet dosage forms using single RP-HPLC method. Trop. J. Pharm. Res. 2013, 12(2), 239–245.
   Web of Science ®Google Scholar